Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,060

The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.

American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus

Open access
Spechler, Stuart J., Sharma, Prateek, Souza, Rhonda F., Inadomi, John M., Shaheen, Nicholas J. · 2011 · Gastroenterology

Abstract

The aim of evidence-based medicine is to improve the quality of health care by integrating the best research evidence with clinical expertise and patient values. Evidence-based clinical guidelines are sets of recommendations intended to assist health care providers and patients in selecting the best management for common clinical situations while accounting for patient-specific circumstances. In addition to providing optimal, patient-centered care and improved outcomes, guidelines can reduce practice variability, identify gaps in evidence, enhance efficiency of resource use, and facilitate development of outcome and performance measures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2011.01.031

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 161

  1. Sharma, 2004, A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop, Gastroenterology, 127, 310, 10.1053/j.gastro.2004.04.010 · doi:10.1053/j.gastro.2004.04.010
  2. McClave, 1987, Early diagnosis of columnar-lined esophagus: a new endoscopic criterion, Gastrointest Endosc, 33, 413, 10.1016/S0016-5107(87)71676-9 · doi:10.1016/s0016-5107(87)71676-9
  3. Choi do, 2002, Endoscopically observed lower esophageal capillary patterns, Korean J Intern Med, 17, 245, 10.3904/kjim.2002.17.4.245 · doi:10.3904/kjim.2002.17.4.245
  4. Vianna, 1987, Normal venous circulation of the gastroesophageal junction, Gastroenterology, 93, 876, 10.1016/0016-5085(87)90453-7 · doi:10.1016/0016-5085(87)90453-7
  5. Spechler, 2004, Intestinal metaplasia at the gastroesophageal junction, Gastroenterology, 126, 567, 10.1053/j.gastro.2003.11.061 · doi:10.1053/j.gastro.2003.11.061
  6. Chandrasoma, 1997, Pathophysiology of Barrett's esophagus, Semin Thorac Cardiovasc Surg, 9, 270
  7. Sharma, 1998, Short segment Barrett's esophagus, Am J Gastroenterol, 93, 1033, 10.1111/j.1572-0241.1998.00324.x · doi:10.1111/j.1572-0241.1998.00324.x · Paper page
  8. Aldulaimi, 2005, Barrett's surveillance is worthwhile and detects curable cancers, Eur J Gastroenterol Hepatol, 17, 943, 10.1097/00042737-200509000-00010 · doi:10.1097/00042737-200509000-00010
  9. Chang, 2007, The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review, Ann Surg, 246, 11, 10.1097/01.sla.0000261459.10565.e9 · doi:10.1097/01.sla.0000261459.10565.e9
  10. Thomas, 2007, Meta analysis: cancer risk in Barrett's oesophagus, Aliment Pharmacol Ther, 26, 1465, 10.1111/j.1365-2036.2007.03528.x · doi:10.1111/j.1365-2036.2007.03528.x
  11. Alcedo, 2009, Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance, Dis Esophagus, 22, 239, 10.1111/j.1442-2050.2008.00908.x · doi:10.1111/j.1442-2050.2008.00908.x
  12. Anderson, 2003, Mortality in Barrett's oesophagus: results from a population based study, Gut, 52, 1081, 10.1136/gut.52.8.1081 · doi:10.1136/gut.52.8.1081
  13. Eckardt, 2001, Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation, Am J Med, 111, 33, 10.1016/S0002-9343(01)00745-8 · doi:10.1016/s0002-9343(01)00745-8
  14. Moayyedi, 2008, Mortality rates in patients with Barrett's oesophagus, Aliment Pharmacol Ther, 27, 316, 10.1111/j.1365-2036.2007.03582.x · doi:10.1111/j.1365-2036.2007.03582.x
  15. Solaymani-Dodaran, 2005, Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study, Am J Gastroenterol, 100, 2616, 10.1111/j.1572-0241.2005.00340.x · doi:10.1111/j.1572-0241.2005.00340.x
  16. Rana, 2000, Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance, Dis Esophagus, 13, 28, 10.1046/j.1442-2050.2000.00069.x · doi:10.1046/j.1442-2050.2000.00069.x
  17. Van der Burgh, 1996, Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus, Gut, 39, 5, 10.1136/gut.39.1.5 · doi:10.1136/gut.39.1.5
  18. Wiklund, 1998, Quality of Life in Reflux and Dyspepsia patients, Eur J Surg Suppl, 41
  19. Shaheen, 2005, Effect of a new diagnosis of Barrett's esophagus on insurance status, Am J Gastroenterol, 100, 577, 10.1111/j.1572-0241.2005.41422.x · doi:10.1111/j.1572-0241.2005.41422.x
  20. Abrams, 2008, Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy, Clin Gastroenterol Hepatol, 6, 30, 10.1016/j.cgh.2007.10.006 · doi:10.1016/j.cgh.2007.10.006
  21. Cooper, 2006, Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence, Aliment Pharmacol Ther, 23, 727, 10.1111/j.1365-2036.2006.02825.x · DOI
  22. Campos, 2001, Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease, Arch Surg, 136, 1267, 10.1001/archsurg.136.11.1267 · doi:10.1001/archsurg.136.11.1267
  23. Falk, 2005, Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer, Clin Gastroenterol Hepatol, 3, 1089, 10.1016/S1542-3565(05)00606-3 · doi:10.1016/s1542-3565(05)00606-3
  24. Corley, 2009, Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994–2006, Gut, 58, 182, 10.1136/gut.2008.163360 · doi:10.1136/gut.2008.163360
  25. Eloubeidi, 2001, Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans, J Clin Gastroenterol, 33, 306, 10.1097/00004836-200110000-00010 · doi:10.1097/00004836-200110000-00010
  26. Srinivasan, 2004, Profile of GERD in the adult population of a northeast urban community, J Clin Gastroenterol, 38, 651, 10.1097/01.mcg.0000135364.12794.e5 · doi:10.1097/01.mcg.0000135364.12794.e5
  27. Spechler, 2002, Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 16, 1795, 10.1046/j.1365-2036.2002.01351.x · doi:10.1046/j.1365-2036.2002.01351.x
  28. Eisen, 1997, The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus [see comments], Am J Gastroenterol, 92, 27
  29. Lieberman, 1997, Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy, Am J Gastroenterol, 92, 1293
  30. Kamat, 2009, Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis, Ann Thorac Surg, 87, 655, 10.1016/j.athoracsur.2008.08.003 · doi:10.1016/j.athoracsur.2008.08.003
  31. Akiyama, 2008, Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men, BMC Gastroenterol, 8, 58, 10.1186/1471-230X-8-58 · doi:10.1186/1471-230x-8-58
  32. Kubo, 2009, Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus, Gastroenterology, 136, 806, 10.1053/j.gastro.2008.11.042 · doi:10.1053/j.gastro.2008.11.042
  33. Kubo, 2009, Cigarette smoking and the risk of Barrett's esophagus, Cancer Causes Control, 20, 303
  34. Rubenstein, 2008, Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus, Am J Gastroenterol, 103, 842, 10.1111/j.1572-0241.2007.01689.x · doi:10.1111/j.1572-0241.2007.01689.x
  35. Playford, 2006, New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus, Gut, 55, 442, 10.1136/gut.2005.083600 · doi:10.1136/gut.2005.083600
  36. Schnell, 2001, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology, 120, 1607, 10.1053/gast.2001.25065 · doi:10.1053/gast.2001.25065
  37. Eloubeidi, 1999, Does this patient have Barrett's esophagus?, Am J Gastroenterol, 94, 937, 10.1111/j.1572-0241.1999.990_m.x · doi:10.1111/j.1572-0241.1999.990_m.x
  38. Chatelain, 2003, High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins, Virchows Arch, 442, 18, 10.1007/s00428-002-0674-1 · doi:10.1007/s00428-002-0674-1
  39. Shaheen, 2001, Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma, Adv Intern Med, 47, 137
  40. Spechler, 2005, Dysplasia in Barrett's esophagus: limitations of current management strategies, Am J Gastroenterol, 100, 927, 10.1111/j.1572-0241.2005.41201.x · doi:10.1111/j.1572-0241.2005.41201.x
  41. Collard, 2002, High-grade dysplasia in Barrett's esophagus, Chest Surg Clin North Am, 12, 77, 10.1016/S1052-3359(03)00067-X · doi:10.1016/s1052-3359(03)00067-x
  42. Konda, 2008, Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?, Clin Gastroenterol Hepatol, 6, 159, 10.1016/j.cgh.2007.09.013 · doi:10.1016/j.cgh.2007.09.013
  43. Rastogi, 2008, Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis, Gastrointest Endosc, 67, 394, 10.1016/j.gie.2007.07.019 · doi:10.1016/j.gie.2007.07.019
  44. Schnell, 2001, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology, 120, 1607, 10.1053/gast.2001.25065 · doi:10.1053/gast.2001.25065
  45. Reid, 2000, Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets, Am J Gastroenterol, 95, 1669
  46. Sharma, 2004, Low-grade dysplasia in Barrett's esophagus, Gastroenterology, 127, 1233, 10.1053/j.gastro.2004.07.061 · doi:10.1053/j.gastro.2004.07.061
  47. Srivastava, 2007, Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus, Am J Gastroenterol, 102, 483, 10.1111/j.1572-0241.2007.01073.x · doi:10.1111/j.1572-0241.2007.01073.x
  48. Fitzgerald, 2001, Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus, Dig Dis Sci, 46, 1892, 10.1023/A:1010678913481 · doi:10.1023/a:1010678913481
  49. Curvers, 2008, Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports, Eur J Gastroenterol Hepatol, 20, 601, 10.1097/MEG.0b013e3282f8295d · doi:10.1097/meg.0b013e3282f8295d
  50. Fountoulakis, 2004, Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer, Br J Surg, 91, 997, 10.1002/bjs.4591 · doi:10.1002/bjs.4591
  51. Kearney, 2003, A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD, Gastrointest Endosc, 57, 823, 10.1016/S0016-5107(03)70015-7 · doi:10.1016/s0016-5107(03)70015-7
  52. Downs-Kelly, 2008, Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies, Am J Gastroenterol, 103, 2333, 10.1111/j.1572-0241.2008.02020.x · doi:10.1111/j.1572-0241.2008.02020.x
  53. van Dekken, 2008, Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus, Am J Clin Pathol, 130, 745, 10.1309/AJCPO31THGVEUIDH · doi:10.1309/ajcpo31thgveuidh
  54. Shi, 2008, p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus, Appl Immunohistochem Mol Morphol, 16, 447, 10.1097/PAI.0b013e318168598b · doi:10.1097/pai.0b013e318168598b
  55. Reid, 2000, Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets, Am J Gastroenterol, 95, 1669
  56. Rabinovitch, 2001, Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables, Am J Gastroenterol, 96, 3071, 10.1111/j.1572-0241.2001.05261.x · doi:10.1111/j.1572-0241.2001.05261.x
  57. Kerkhof, 2008, Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus, Cancer Biomark, 4, 1, 10.3233/CBM-2008-4101 · doi:10.3233/cbm-2008-4101
  58. Huang, 2008, Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma, BMC Clin Pathol, 8, 5, 10.1186/1472-6890-8-5 · doi:10.1186/1472-6890-8-5
  59. Rygiel, 2008, Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens, Genes Chromosomes Cancer, 47, 396, 10.1002/gcc.20543 · doi:10.1002/gcc.20543
  60. Cestari, 2007, Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study, Cancer Lett, 251, 278, 10.1016/j.canlet.2006.11.033 · doi:10.1016/j.canlet.2006.11.033
  61. Rygiel, 2007, Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population, Cancer, 109, 1980, 10.1002/cncr.22643 · doi:10.1002/cncr.22643
  62. Nelson, 2000, High resolution and high-magnification endoscopy: September 2000, Gastrointest Endosc, 52, 864, 10.1016/S0016-5107(00)70225-2 · doi:10.1016/s0016-5107(00)70225-2
  63. Sharma, 2005, Magnification endoscopy, Gastrointest Endosc, 61, 435, 10.1016/S0016-5107(04)02736-1 · doi:10.1016/s0016-5107(04)02736-1
  64. Yao, 2006, Magnification endoscopy outlines the microvascular architecture and extent of Barrett's intramucosal carcinoma prior to endoscopic resection, Gastrointest Endosc, 63, 1064, 10.1016/j.gie.2006.01.004 · doi:10.1016/j.gie.2006.01.004
  65. Wani, 2007, Endoscopic surface imaging of Barrett's esophagus: an optimistic view, Gastroenterology, 133, 11, 10.1053/j.gastro.2007.05.062 · doi:10.1053/j.gastro.2007.05.062
  66. Kara, 2005, A randomized cross-over study comparing light-induced fluorescence endoscopy with standard video endoscopy for the detection of early neoplasia in Barrett's esophagus, Gastrointest Endosc, 61, 671, 10.1016/S0016-5107(04)02777-4 · doi:10.1016/s0016-5107(04)02777-4
  67. Kara, 2005, High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study, Endoscopy, 37, 929, 10.1055/s-2005-870433 · doi:10.1055/s-2005-870433
  68. Canto, 2001, Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study, Endoscopy, 33, 391, 10.1055/s-2001-14427 · doi:10.1055/s-2001-14427
  69. Sharma, 2001, Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus, Gastrointest Endosc, 54, 289, 10.1067/mge.2001.115728 · doi:10.1067/mge.2001.115728
  70. Breyer, 2003, Does methylene blue detect intestinal metaplasia in Barrett's esophagus?, Gastrointest Endosc, 57, 505, 10.1067/mge.2003.137 · doi:10.1067/mge.2003.137
  71. Horwhat, 2008, A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus, Am J Gastroenterol, 103, 546, 10.1111/j.1572-0241.2007.01601.x · doi:10.1111/j.1572-0241.2007.01601.x
  72. Lim, 2006, Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus, Gastrointest Endosc, 64, 195, 10.1016/j.gie.2005.07.025 · doi:10.1016/j.gie.2005.07.025
  73. Meining, 2004, Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction, Endoscopy, 36, 160, 10.1055/s-2004-814183 · doi:10.1055/s-2004-814183
  74. Sharma, 2003, Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus, Gut, 52, 24, 10.1136/gut.52.1.24 · doi:10.1136/gut.52.1.24
  75. Guelrud, 1998, Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy, Gastrointest Endosc, 47, 512, 10.1016/S0016-5107(98)70253-6 · doi:10.1016/s0016-5107(98)70253-6
  76. Ngamruengphong, 2009, Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis, Gastrointest Endosc, 69, 1021, 10.1016/j.gie.2008.06.056 · doi:10.1016/j.gie.2008.06.056
  77. Guelrud, 2001, Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus, Gastrointest Endosc, 53, 559, 10.1067/mge.2001.114059 · doi:10.1067/mge.2001.114059
  78. Pohl, 2007, Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus, Endoscopy, 39, 594, 10.1055/s-2007-966649 · doi:10.1055/s-2007-966649
  79. Kara, 2006, Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging, Gastrointest Endosc, 64, 155, 10.1016/j.gie.2005.11.049 · doi:10.1016/j.gie.2005.11.049
  80. Curvers, 2008, Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus, Gastroenterology, 134, 670, 10.1053/j.gastro.2008.01.003 · doi:10.1053/j.gastro.2008.01.003
  81. Wolfsen, 2008, Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus, Gastroenterology, 135, 24, 10.1053/j.gastro.2008.03.019 · doi:10.1053/j.gastro.2008.03.019
  82. Sharma, 2009, Detection of metaplasia and neoplasia in patients with Barrett's esophagus using high-definition white light endoscopy versus narrow band imaging: a prospective, multi-center, randomized, crossover trial, Gastrointest Endosc, 69, AB135, 10.1016/j.gie.2009.03.181 · doi:10.1016/j.gie.2009.03.181
  83. Kara, 2005, Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus, Gastrointest Endosc, 61, 679, 10.1016/S0016-5107(04)02577-5 · doi:10.1016/s0016-5107(04)02577-5
  84. Kara, 2006, Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus, Gastrointest Endosc, 64, 176, 10.1016/j.gie.2005.11.050 · doi:10.1016/j.gie.2005.11.050
  85. Curvers, 2008, Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus; a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system, Gut, 57, 167, 10.1136/gut.2007.134213 · doi:10.1136/gut.2007.134213
  86. Meining, 2007, In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis, Clin Gastroenterol Hepatol, 5, 1261, 10.1016/j.cgh.2007.05.019 · doi:10.1016/j.cgh.2007.05.019
  87. Kumagai, 2004, Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system, Endoscopy, 36, 590, 10.1055/s-2004-814533 · doi:10.1055/s-2004-814533
  88. Pohl, 2007, Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus, Endoscopy, 39, 492, 10.1055/s-2007-966340 · doi:10.1055/s-2007-966340
  89. Georgakoudi, 2001, Fluorescence, reflectance and light scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus, Gastroenterology, 120, 1620, 10.1053/gast.2001.24842 · doi:10.1053/gast.2001.24842
  90. Kobayashi, 1998, High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results, Gastrointest Endosc, 47, 515, 10.1016/S0016-5107(98)70254-8 · doi:10.1016/s0016-5107(98)70254-8
  91. Bouma, 2000, High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography, Gastrointest Endosc, 51, 467, 10.1016/S0016-5107(00)70449-4 · doi:10.1016/s0016-5107(00)70449-4
  92. Poneros, 2001, Diagnosis of specialized metaplasia by optical coherence tomography, Gastroenterology, 120, 7, 10.1053/gast.2001.20911 · doi:10.1053/gast.2001.20911
  93. Evans, 2006, Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gastroenterol Hepatol, 4, 38, 10.1016/S1542-3565(05)00746-9 · doi:10.1016/s1542-3565(05)00746-9
  94. Qi, 2006, Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography, J Biomed Opt, 11, 044010, 10.1117/1.2337314 · doi:10.1117/1.2337314
  95. Cooper, 2006, Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence, Aliment Pharmacol Ther, 23, 727, 10.1111/j.1365-2036.2006.02825.x · DOI
  96. Peters, 2000, Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus, Scand J Gastroenterol, 35, 1238, 10.1080/003655200453557 · doi:10.1080/003655200453557
  97. Kim, 2007, Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats, Yonsei Med J, 48, 1020, 10.3349/ymj.2007.48.6.1020 · doi:10.3349/ymj.2007.48.6.1020
  98. Kaur, 2002, Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus, Gastroenterology, 123, 60, 10.1053/gast.2002.34244 · doi:10.1053/gast.2002.34244
  99. Yeh, 2003, Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus, Dis Esophagus, 16, 193, 10.1046/j.1442-2050.2003.00327.x · doi:10.1046/j.1442-2050.2003.00327.x
  100. Gerson, 2004, Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors, Aliment Pharmacol Ther, 20, 637, 10.1111/j.1365-2036.2004.02127.x · doi:10.1111/j.1365-2036.2004.02127.x
  101. McCallum, 1991, Role of anti-reflux surgery against dysplasia in Barrett's esophagus (abstr), Gastroenterology, 100, A121
  102. Katz, 1998, The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus, Am J Gastroenterol, 93, 536, 10.1111/j.1572-0241.1998.161_b.x · DOI
  103. Oberg, 2005, Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma, Ann Surg, 242, 49, 10.1097/01.sla.0000167864.46462.9f · doi:10.1097/01.sla.0000167864.46462.9f
  104. Corey, 2003, Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus?, Am J Gastroenterol, 98, 2390, 10.1111/j.1572-0241.2003.08702.x · doi:10.1111/j.1572-0241.2003.08702.x
  105. Feith, 2003, Pattern of lymphatic spread of Barrett's cancer, World J Surg, 27, 1052, 10.1007/s00268-003-7060-2 · doi:10.1007/s00268-003-7060-2
  106. Peyre, 2007, Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia, Ann Surg, 246, 665, 10.1097/SLA.0b013e318155a7a1 · doi:10.1097/sla.0b013e318155a7a1
  107. Falk, 1994, Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia, Gastrointest Endosc, 40, 207, 10.1016/S0016-5107(94)70168-7 · doi:10.1016/s0016-5107(94)70168-7
  108. Waxman, 2006, High frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia or intramucosal carcinoma: a case series, Am J Gastroenterol, 101, 1773, 10.1111/j.1572-0241.2006.00617.x · doi:10.1111/j.1572-0241.2006.00617.x
  109. Larghi, 2005, EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus, Gastrointest Endosc, 62, 16, 10.1016/S0016-5107(05)00319-6 · doi:10.1016/s0016-5107(05)00319-6
  110. Prasad, 2007, Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus, Am J Gastroenterol, 102, 2380, 10.1111/j.1572-0241.2007.01419.x · doi:10.1111/j.1572-0241.2007.01419.x
  111. Giovannini, 2004, Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer, Endoscopy, 36, 782, 10.1055/s-2004-825813 · doi:10.1055/s-2004-825813
  112. Seewald, 2003, Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma, Gastrointest Endosc, 57, 854, 10.1016/S0016-5107(03)70020-0 · doi:10.1016/s0016-5107(03)70020-0
  113. Conio, 2005, Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience, World J Gastroenterol, 11, 6650, 10.3748/wjg.v11.i42.6650 · doi:10.3748/wjg.v11.i42.6650
  114. Soehendra, 2006, Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video), Gastrointest Endosc, 63, 847, 10.1016/j.gie.2005.06.052 · doi:10.1016/j.gie.2005.06.052
  115. Larghi, 2007, Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma, Endoscopy, 39, 1086, 10.1055/s-2007-966788 · doi:10.1055/s-2007-966788
  116. Lopes, 2007, Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma, Surg Endosc, 21, 820, 10.1007/s00464-006-9187-3 · doi:10.1007/s00464-006-9187-3
  117. Montes, 1999, Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus, Gastrointest Endosc, 50, 173, 10.1016/S0016-5107(99)70220-8 · doi:10.1016/s0016-5107(99)70220-8
  118. Sampliner, 2001, Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study, Gastrointest Endosc, 53, 554, 10.1067/mge.2001.114418 · doi:10.1067/mge.2001.114418
  119. Sharma, 2006, A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results, Gut, 55, 1233, 10.1136/gut.2005.086777 · doi:10.1136/gut.2005.086777
  120. Dulai, 2005, Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus, Gastrointest Endosc, 61, 232, 10.1016/S0016-5107(04)02576-3 · doi:10.1016/s0016-5107(04)02576-3
  121. Mork, 2007, High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation, Scand J Gastroenterol, 42, 23, 10.1080/00365520600825125 · doi:10.1080/00365520600825125
  122. Kelty, 2004, Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation, Aliment Pharmacol Ther, 20, 1289, 10.1111/j.1365-2036.2004.02277.x · doi:10.1111/j.1365-2036.2004.02277.x
  123. Sharma, 2007, Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients, Gastrointest Endosc, 65, 185, 10.1016/j.gie.2006.09.033 · doi:10.1016/j.gie.2006.09.033
  124. Fleischer, 2008, Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up, Gastrointest Endosc, 68, 867, 10.1016/j.gie.2008.03.008 · doi:10.1016/j.gie.2008.03.008
  125. Manner, 2006, Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation, Am J Gastroenterol, 101, 1762, 10.1111/j.1572-0241.2006.00709.x · doi:10.1111/j.1572-0241.2006.00709.x
  126. Familiari, 2003, Endoscopic treatment of Barrett's epithelium with argon plasma coagulation, Minerva Gastroenterol Dietol, 49, 63
  127. Ragunath, 2005, Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness, Scand J Gastroenterol, 40, 750, 10.1080/00365520510015737 · doi:10.1080/00365520510015737
  128. Sharma, 2009, Circumferential and focal ablation of Barrett's esophagus containing dysplasia, Am J Gastroenterol, 104, 310, 10.1038/ajg.2008.142 · doi:10.1038/ajg.2008.142
  129. Peters, 2006, Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study, Am J Gastroenterol, 101, 1449, 10.1111/j.1572-0241.2006.00635.x · DOI · Paper page
  130. Ganz, 2008, Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia a U.S. multicenter registry, Gastrointest Endosc, 68, 35, 10.1016/j.gie.2007.12.015 · doi:10.1016/j.gie.2007.12.015
  131. Johnston, 2005, Cryoablation of Barrett's esophagus: a pilot study, Gastrointest Endosc, 62, 842, 10.1016/j.gie.2005.05.008 · doi:10.1016/j.gie.2005.05.008
  132. Dumot, 2009, An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients, Gastrointest Endosc, 70, 635, 10.1016/j.gie.2009.02.006 · doi:10.1016/j.gie.2009.02.006
  133. Attwood, 2003, Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus, Clin Gastroenterol Hepatol, 1, 258, 10.1016/S1542-3565(03)00128-9 · doi:10.1016/s1542-3565(03)00128-9
  134. Bronner, 2009, Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia, Gastroenterology, 136, 56, 10.1053/j.gastro.2008.10.012 · doi:10.1053/j.gastro.2008.10.012
  135. Van Lanschot, 2001, Hospital volume and hospital mortality for esophagectomy, Cancer, 91, 1574, 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2 · doi:10.1002/1097-0142(20010415)91:8<1574::aid-cncr1168>3.0.co;2-2
  136. Prasad, 2009, Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus, Gastroenterology, 137, 815, 10.1053/j.gastro.2009.05.059 · doi:10.1053/j.gastro.2009.05.059
  137. Wang, 2009, Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience, Gastrointest Endosc, 69, 777, 10.1016/j.gie.2008.05.013 · doi:10.1016/j.gie.2008.05.013
  138. Altorki, 2008, Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment, Ann Surg, 247, 434, 10.1097/SLA.0b013e318163a2ff · doi:10.1097/sla.0b013e318163a2ff
  139. Munítiz, 2007, [Surgical treatment of high-grade dysplasia in Barrett's esophagus, ] Cir Esp, 82, 214, 10.1016/S0009-739X(07)71709-8 · doi:10.1016/s0009-739x(07)71709-8
  140. Williams, 2007, Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome, J Gastrointest Surg, 11, 1589, 10.1007/s11605-007-0330-9 · doi:10.1007/s11605-007-0330-9
  141. Peyre, 2007, Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia, Ann Surg, 246, 665, 10.1097/SLA.0b013e318155a7a1 · doi:10.1097/sla.0b013e318155a7a1
  142. Chang, 2006, Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus, J Gastrointest Surg, 10, 341, 10.1016/j.gassur.2005.12.007 · doi:10.1016/j.gassur.2005.12.007
  143. Sujendran, 2005, Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus, Eur J Cardiothorac Surg, 28, 763, 10.1016/j.ejcts.2005.08.018 · doi:10.1016/j.ejcts.2005.08.018
  144. Reed, 2005, Surgical treatment of esophageal high-grade dysplasia, Ann Thorac Surg, 79, 1110, 10.1016/j.athoracsur.2004.09.006 · doi:10.1016/j.athoracsur.2004.09.006
  145. Heitmiller, 2003, Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia, Langenbecks Arch Surg, 388, 83, 10.1007/s00423-002-0343-5 · doi:10.1007/s00423-002-0343-5
  146. Thomson, 2003, Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus, ANZ J Surg, 73, 121, 10.1046/j.1445-2197.2003.02646.x · doi:10.1046/j.1445-2197.2003.02646.x
  147. Tseng, 2003, Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome—an update, J Gastrointest Surg, 7, 164, 10.1016/S1091-255X(02)00153-1 · doi:10.1016/s1091-255x(02)00153-1
  148. Perry, 2002, Minimally invasive esophagectomy in the elderly, JSLS, 6, 299
  149. Scott Bolton, 2001, Esophagectomy for adenocarcinoma in patients 45 years of age and younger, J Gastrointest Surg, 5, 620, 10.1016/S1091-255X(01)80104-9 · doi:10.1016/s1091-255x(01)80104-9
  150. Zaninotto, 2000, Oesophageal resection for high-grade dysplasia in Barrett's oesophagus, Br J Surg, 87, 1102, 10.1046/j.1365-2168.2000.01470.x · doi:10.1046/j.1365-2168.2000.01470.x
  151. Nguyen, 2000, Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia, Surgery, 127, 284, 10.1067/msy.2000.103489 · doi:10.1067/msy.2000.103489
  152. Catrambone, 1999, Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia, Minerva Chir, 54, 657
  153. Patti, 1999, Barrett's esophagus: a surgical disease, J Gastrointest Surg, 3, 397, 10.1016/S1091-255X(99)80056-0 · doi:10.1016/s1091-255x(99)80056-0
  154. Luketich, 1998, Minimally invasive approach to esophagectomy, JSLS, 2, 243
  155. Lerut, 1994, Surgical treatment of Barrett's carcinoma, J Thorac Cardiovasc Surg, 107, 1059, 10.1016/S0022-5223(94)70381-7 · doi:10.1016/s0022-5223(94)70381-7
  156. Parameswaran, 2008, The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review, Ann Surg Oncol, 15, 2372, 10.1245/s10434-008-0042-8 · DOI
  157. Dresner, 2003, Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia, Br J Surg, 90, 1120, 10.1002/bjs.4169 · doi:10.1002/bjs.4169
  158. Franchimont, 2003, Newly developed Barrett's esophagus after subtotal esophagectomy, Endoscopy, 35, 850, 10.1055/s-2003-42623 · doi:10.1055/s-2003-42623
  159. da Rocha, 2008, Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up, Ann Surg Oncol, 15, 2903, 10.1245/s10434-008-0057-1 · doi:10.1245/s10434-008-0057-1
  160. Gutschow, 2008, Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment, Dis Esophagus, 21, E6, 10.1111/j.1442-2050.2007.00784.x · doi:10.1111/j.1442-2050.2007.00784.x
  161. Wolfsen, 2004, Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy, BMC Gastroenterol, 4, 18, 10.1186/1471-230X-4-18 · doi:10.1186/1471-230x-4-18

Cited by

See all 1,060

Metadata

Authors
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2011-03
Volume
140
Issue
3
Pages
e18-e52
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2024455739
Cited by
1,060
References
164
FWCI
95.53
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.